Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07369726
Recruiting Not applicable

Effects of Mobilization and Caffeine After Cesarean

NCT07369726 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-25
Last updated
2026-08-18

Condition(s) studied

Gastrointestinal MotilityPostoperative PainPsychological Well-Being

Investigational drug(s) / intervention(s)

caffeine consumptionDecaffeinated coffee

caffeine consumption: The women in the intervention group will be mobilised at the 4-hour mark. The intervention group will be given caffeinated Turkish coffee at 6-hour intervals.

Decaffeinated coffee: The women in the control group will be mobilised at the 6-hour mark. The control group will be given decaffeinated Turkish coffee at 6-hour intervals.

Study summary

This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Being between 18 and 35 years of age, 2. Women who underwent cesarean delivery under spinal anesthesia, 3. Having a post-cesarean pain level of 4 or higher, 4. Being able to understand and write Turkish and communicate effectively with researchers. Exclusion Criteria: 1. Women who underwent emergency cesarean delivery, 2. Those with pregnancy complications (preeclampsia, placenta previa, etc.), 3. Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis), 4. Those with sensitivity or allergy to caffeine, 5. Those with a history of chronic pain syndrome or dependence on analgesics, 6. Regular coffee drinkers (≥2 cups per day), 7. Intraoperative complications such as bowel or bladder injury, i) Those who cannot comply with the study protocol or complete the follow-up process. Removal Criteria: 1. Participants are excluded from the study under the following conditions: 2. During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding), 3. Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn, 4. Development of severe postoperative nausea, vomiting, or intolerance to oral intake, 5. Inability to consume or refusal to consume coffee according to the study protocol, 6. Withdrawal of consent by the participant at any point during the study, 7. Failure to comply with surgical procedures or loss of follow-up, 8. Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
KTO Karatay University Konya Konya Recruiting

More KTO Karatay University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07369726 on ClinicalTrials.gov ↗ ← All trials in Turkey